Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension

Christian Nagel,Ralf Ewert,Benjamin Egenlauf,H. Lehmkuhl,Stephan Rosenkranz,Nicola Benjamin,Vedat Schwenger,Felix J.F. Herth,Ekkehard Grünig

Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension

2017

Christian Nagel
Ralf Ewert
Benjamin Egenlauf
H. Lehmkuhl
Stephan Rosenkranz
Nicola Benjamin
Vedat Schwenger
Felix J.F. Herth
Ekkehard Grünig

Background: Despite optimized medical therapy, severe idiopathic pulmonary arterial hypertension (IPAH) is a devastating disease with a poor outcome. Autoantibodi

Keywords:

Immunoadsorption
Autoantibody
Disease
Idiopathic Pulmonary Arterial Hypertension
Plasmapheresis
Diabetes mellitus
Medicine
Cardiology
Internal medicine
Quality of life
Vascular resistance
Prospective cohort study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations